Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
330.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.20 (0.364%)
Market Cap: £1.75b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Interim 2020 Dividend/Enhanced Script Correction

16 Dec 2020 12:00

RNS Number : 8736I
Hammerson PLC
16 December 2020
 

Hammerson plc (the 'Company')

16 December 2020

 

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative - Correction

 

The following amendment has been made to the Interim 2020 Dividend and Enhanced Scrip Dividend Alternative announcement released on 8 December 2020 at 13:15 under RNS No 9480H.

 

Therefore, 225,830,124 New Shares will be admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange, rather than 189,816,827 New Shares admitted to trading on the London Stock Exchange and 36,013,297 New Shares admitted to trading on the Johannesburg Stock Exchange, as stated in the main body of the announcement.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Hammerson plc

 

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative

 

16 December 2020

 

Further to the announcement of the Interim 2020 Dividend and the Enhanced Scrip Dividend Alternative on 11 November 2020, the Board of Hammerson plc (the Company) announced that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,108,216,704 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 225,830,124.

 

Therefore, 225,830,124 New Shares will be admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange, bringing the total number of issued 5 pence ordinary shares in the Company to 4,057,298,174.

 

The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange and the Johannesburg Stock Exchange on 18 December 2020. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchange. Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated 11 November 2020 in connection with the proposed Interim 2020 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/shareholderinformation/general-meeting.

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

Enquiries

Josh Warren, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVKKABBDBDDPBD
Date   Source Headline
28th Aug 20259:30 amRNSHolding(s) in Company
27th Aug 20259:00 amRNSDividend Currency Conversion Announcement
19th Aug 20253:00 pmRNSHolding(s) in Company
15th Aug 20258:15 amRNSTotal Voting Rights
12th Aug 202510:00 amRNSAnnouncement of Applications for Second Admission
8th Aug 20253:15 pmRNSAnnouncement of SARB Approval
8th Aug 20257:00 amRNSAcquisition
7th Aug 20258:00 amRNSHolding(s) in Company
5th Aug 20253:00 pmRNSTotal Voting Rights
5th Aug 20258:15 amRNSTotal Voting Rights
1st Aug 20253:00 pmRNSTotal Voting Rights
31st Jul 20254:40 pmRNSRESULTS OF PLACING
31st Jul 20257:30 amRNSTransaction in Own Shares
31st Jul 20257:02 amRNSDividend Declaration
31st Jul 20257:01 amRNSPROPOSED PLACING TO FUND ACQUISITION
31st Jul 20257:00 amRNSHalf-year Report
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20254:30 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20254:15 pmRNSTotal Voting Rights
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20254:45 pmRNSTotal Voting Rights
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20252:30 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20254:00 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20253:30 pmRNSTotal Voting Rights
30th Jun 202510:00 amRNSNotice of Results
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20253:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.